Stifel reiterates sell rating on Aurora Cannabis after its acquisition of TerrFarma

Stifel analyst W. Andrew Carter on Wednesday reiterated his sell rating for Aurora Cannabis Inc. ACB, +6.87% ACB, +0.66% after the Canadian cannabis company announced plans to buy TerraFarma Inc., the...